| Name | Title | Contact Details |
|---|
ProLung`s mission is to make a difference in time for lung cancer patients. ProLung is a leader in innovative predictive analytics technology and non-invasive biomarkers for the risk stratification of lung cancer. The Company develops, tests, and commercializes solutions which may shorten the time to diagnosis and expand the therapeutic window for lung cancer patients.
History and background - Magellan Biosciences, Inc. was established in October 2004 through the combination of ESA Biosciences and Dynex Technologies - which addressed emerging growth markets in biomedical research and clinical diagnostics. In November
dermpath diagnostics is a Palm Beach Gardens, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AthoGen is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AlohaCare is a Honolulu, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.